Urges and requests certain state universities to pursue opportunities for research on the safety and clinical efficacy of therapeutic marijuana
Impact
The resolution aligns with previous legislation, such as Act No. 96 from the 2016 Regular Session, which allows therapeutic marijuana access for patients with specific debilitating conditions. HR189 could significantly enhance the body of research available to inform both clinical practices and regulatory policies relating to marijuana use, thus impacting treatment protocols for vulnerable patient populations covered under the law.
Summary
House Resolution 189 (HR189) urges and requests several Louisiana State Universities, including Health Sciences Centers at New Orleans and Shreveport, as well as the Pennington Biomedical Research Center, to explore research opportunities focused on the safety and clinical efficacy of marijuana for therapeutic uses. This bill reflects a growing recognition of the need for sound scientific evidence regarding the medicinal benefits of marijuana, especially given the legal changes surrounding cannabis use across various states.
Sentiment
The general sentiment surrounding HR189 appears to be positive, emphasizing the necessity for thorough research to ensure patient safety and efficacy. Supporters of the resolution believe that a scientific approach can bolster confidence in the use of therapeutic marijuana and assist healthcare providers in making informed decisions. The bill reflects a growing consensus on the importance of understanding the therapeutic potential of marijuana in treating various conditions.
Contention
While there may not be strong opposition evident from legislative discussions or voting records, the contention could arise from differing views on marijuana use for therapeutic purposes. Some stakeholders may emphasize the need for rigorous testing and regulation, while others might advocate for broader accessibility of marijuana treatments. Furthermore, as research develops, new findings could spark debates about the scope of conditions warranting marijuana use in therapy.
Urges and requests certain state universities and research entities to pursue opportunities for research on the safety and clinical efficacy of therapeutic marijuana.
Urges and requests state entities that have a role in the implementation of Act No. 96 of the 2016 Regular Session relative to patient access to therapeutic marijuana to prioritize fully implementing the law as soon as possible
Authorizes certain universities to conduct research and testing of state-regulated industrial hemp, CBD, and medical marijuana products (OR INCREASE GF EX See Note)
Reforms the state systems for regulating the production of marijuana for therapeutic use and for the dispensing of such product (EN INCREASE SG EX See Note)
Urges and requests the Dept. of Health and Hospitals and LSU Board of Supervisors to conduct a study assessing the current and future delivery of health care and medical education in La. and to make recommendations
Urging the Medical Marijuana Advisory Board to encourage and facilitate State System of Higher Education universities to secure United States Drug Enforcement Administration registrations to authorize the possession of cannabis for clinical registrants to engage in hands-on work regarding cultivating, testing, processing and researching cannabis plants.
Medical marijuana; taxes on retail sales; providing for the permanent revocation of license for nonpayment of taxes; research license; inspections; effective date.
Medical marijuana; taxes on retail sales; providing for the permanent revocation of license for nonpayment of taxes; research license; inspections; effective date.